glp-1 fda approved for pcos The dual impact of receptor agonists on metabolic and reproductive health in polycystic ovary syndrome: insights from human and animal trials Weight loss drugs could help

These trials were not primarily powered for hard kidney outcomes (eGFR slope, kidney failure, kidney replacement therapy), but they established albuminuria lowering as a reproducible effect and framed subsequent kidney-focused development programs

Currently, the majority of research has used cellular and animal models, with mature clinical trial data lacking

Processes like autophagy and re-dox systems help us to do so

Consistent with this notion, increased expression of adipogenic genes and a decrease in resistin expression was reported in -arrestin 1 knockout mice 49

having the right tools can make all the difference

That extra month of escalation gives the body more time to adapt and may contribute to tirzepatide's superior tolerability despite higher absolute doses